Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 13, 2024Current OncologyOpen Access

Mogamulizumab and Concomitant Hypofractionated Low-Dose Total Skin Electron Beam Therapy (2 × 4 Gy) in Cutaneous T-Cell Lymphoma: Proof of Principle, Report of Two Cases

View Full Paper
Ask AI
Bookmark
Share

Authors

MOMathias OymannsHelios Klinikum KrefeldMDMichael Daum-MarzianHelios Klinikum KrefeldCAChalid AssafMSH Medical School Hamburg – University of Applied Sciences and Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Oymanns et al. (2024) studied this question.

synapsesocial.com/papers/68e58930b6db643587525586https://doi.org/10.3390/curroncol31090400
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management2021 · 46 citations
  2. 2Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG)2007 · 117 citations
  3. 3Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sézary syndrome: A multicentre, retrospective, real‐world French study2023 · 50 citations
  4. 4Mogamulizumab‐associated rash – Case series and review of the literature2024 · 13 citations
  5. 5Low‐dose total skin electron beam therapy plus oral bexarotene maintenance therapy for cutaneous T‐cell lymphoma2022 · 26 citations